PCSK9 and LDLR trafficking in hepatocytes

被引：0
|
作者：
Zhang, Da-Wei [1 ]
Garuti, Rita [1 ]
Lagace, Tom [1 ]
Horton, Jay [1 ]
Cohen, Jonathan C. [1 ]
Hobbs, Helen H. [1 ]
机构：
[1] Univ Texas, SW Med Ctr, Dallas, TX USA
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2007年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E115 / E115
页数：1
相关论文
共 50 条
  • [21] PCSK9 and LDLR The Yin-Yang in the Cellular Uptake of Cholesterol
    Morales-Villegas, Enrique
    CURRENT HYPERTENSION REVIEWS, 2013, 9 (04) : 310 - 323
  • [22] Pcsk9 Knockout Aggravated Experimental Apical Periodontitis via LDLR
    Huang, L.
    Wu, H.
    Wu, Y.
    Song, F.
    Zhang, L.
    Li, Z.
    Sun, H.
    Huang, C.
    JOURNAL OF DENTAL RESEARCH, 2022, 101 (01) : 83 - 92
  • [23] The cellular trafficking of the secretory proprotein convertase PCSK9 and its dependence on the LDLR (vol 8, pg 718, 2007)
    Nassoury, Nasha
    Blasiole, Daniel A.
    Oler, Angie Tebon
    Benjannet, Suzanne
    Hamelin, Josee
    Poupon, Vivianne
    McPherson, Peter S.
    Attie, Alan D.
    Prat, Annik
    Seidah, Nabil G.
    TRAFFIC, 2007, 8 (07) : 950 - 950
  • [24] Effects of PCSK9 Inhibition on Plasma PCSK9 Concentration and Hepatic PCSK9 Expression
    Shapiro, Michael D.
    Tavori, Hagai
    Oleaga, Carlota
    Miles, Joshua
    Fazio, Sergio
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38
  • [25] SOLUBLE LDLR ASSOCIATES WITH MULTIPLE LIPOPROTEIN PARAMETERS IN A CAUCASIAN POPULATION AND ITS ASSOCIATION WITH SERUM PCSK9 IS AFFECTED BY PCSK9 LOSS OF FUNCTION
    Mayne, Janice
    Tepliakova, Lioudmila
    Seebun, Deeptee
    Walker, Krystal
    Mohottalage, Dhanuddara
    Ning, Zhibin
    Abujrad, Hussein
    Mbikay, Majambu
    Wassef, Hanny
    Chretien, Michel
    Ooi, Teik Chye
    Figeys, Daniel
    ATHEROSCLEROSIS SUPPLEMENTS, 2018, 32 : 9 - 9
  • [26] PCSK9
    Abifadel, M.
    Boileau, C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [27] In Vivo Evidence That Furin from Hepatocytes Inactivates PCSK9
    Essalmani, Rachid
    Susan-Resiga, Delia
    Chamberland, Ann
    Abifadel, Marianne
    Creemers, John W.
    Boileau, Catherine
    Seidah, Nabil G.
    Prat, Annik
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (06) : 4257 - 4263
  • [28] Variation at the PCSK9 and LDLR locus, LDL levels, and heart disease in PROSPER
    Polisecki, Eliana
    Muallem, Hind
    Maeda, Nolbuyo
    Trompet, Stella
    Julkema, Wouter
    McMahon, Alex
    Robetson, Michele
    Ford, Ian
    Blauw, Gerard
    Murphy, Michael
    Shepherd, James
    Schaefer, Ernst
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (06) : E116 - E116
  • [29] Euphornin L promotes lipid clearance by dual regulation of LDLR and PCSK9
    Li, Huihui
    Li, Jun
    Zhang, Xianjing
    Li, Jiaomeng
    Xi, Cong
    Wang, Wenqiong
    Lu, Youli
    Xuan, Lijiang
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (06)
  • [30] PCSK9 analysis in familial hypercholesterolaemia patients negative for LDLR and APOB mutations
    George, P. M.
    Homer, V. M.
    Laurie, A. D.
    Hurndell, N.
    Scott, R. S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 135 - 135
12345